AI assistant
Sending…
Predictive Oncology Inc. — Director's Dealing 2013
Aug 19, 2013
35106_dirs_2013-08-19_3457ecf4-1b3f-4222-a588-f477afde63f0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2013-08-16
Reporting Person: Herschkowitz Samuel (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-08-16 | Common Stock, par value $0.01 per share | P | 23000 | $0.21 | Acquired | 46619414 | Direct |
More from Predictive Oncology Inc.
Regulatory Filings
2026
Jul 20
Capital/Financing Update
2026
Jul 2
Capital/Financing Update
2026
Jun 9
Regulatory Filings
2026
Jun 9
Earnings Release
2026
May 15
Capital/Financing Update
2026
May 15
Capital/Financing Update
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 22